Nevro Corp. - Investors

Investors

About Nevro

About Nevro

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. Senza systems are the only SCS systems that delivers Nevro's proprietary HF10® therapy.

Our Commitment to ESG

We recognize the growing importance of ESG to our stakeholders: customers, patients, shareholders, employees, suppliers and communities. We are committed to operating our business as a responsible corporate citizen and strengthening the trust our stakeholders place in us.

– D. Keith Grossman, Chairman, CEO and President

View ESG Report
Esg
Annual Report

Annual Reports

Access our annual report providing the financial profile and achievements of the prior year
Leadership

Leadership

Meet the group of experienced executives committed to our mission.
Outcomes

Outcomes

Access the clinical evidence portfolio supporting our technology

Event RSS Feed (opens in new window) Latest Events and Presentations

All events and presentations

Press Release RSS Feed (opens in new window) News Releases

More News

Contact Nevro